114 related articles for article (PubMed ID: 16053486)
1. Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma.
Mega S; Miyamoto M; Ebihara Y; Takahashi R; Hase R; Li L; Shichinohe T; Kawarada Y; Uehara H; Kaneko H; Hashimoto H; Murakami Y; Itoh T; Morikawa T; Kondo S
Dis Esophagus; 2005; 18(2):109-13. PubMed ID: 16053486
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression.
Ebihara Y; Miyamoto M; Shichinohe T; Kawarada Y; Cho Y; Fukunaga A; Murakami S; Uehara H; Kaneko H; Hashimoto H; Murakami Y; Itoh T; Okushiba S; Kondo S; Katoh H
Dis Esophagus; 2004; 17(2):150-4. PubMed ID: 15230729
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
Saberwal G; Broderick E; Janssen I; Shetty V; Alvi S; Lisak L; Venugopal P; Raza A; Mundle SD
J Hematother Stem Cell Res; 2003 Aug; 12(4):443-50. PubMed ID: 12965081
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma.
Hou X; Liang RB; Wei JC; Xu Y; Fu JH; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
Oncotarget; 2016 May; 7(21):31088-96. PubMed ID: 27145270
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
8. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Int J Oncol; 2011 Jul; 39(1):155-9. PubMed ID: 21537837
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Kaibara N
J Cancer Res Clin Oncol; 2001 Sep; 127(9):531-6. PubMed ID: 11570573
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M
Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282
[TBL] [Abstract][Full Text] [Related]
11. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
[TBL] [Abstract][Full Text] [Related]
14. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis.
Zhao J; Li L; Wei S; Gao Y; Chen Y; Wang G; Wu Z
Dis Esophagus; 2012 Aug; 25(6):520-6. PubMed ID: 22098104
[TBL] [Abstract][Full Text] [Related]
16. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy].
Zhu S; Zhai F; Yin W
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):129-31. PubMed ID: 10920963
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities.
Sarbia M; Stahl M; Fink U; Heep H; Dutkowski P; Willers R; Seeber S; Gabbert HE
Int J Cancer; 1999 Feb; 84(1):86-91. PubMed ID: 9988238
[TBL] [Abstract][Full Text] [Related]
20. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Fujita Y; Sakakura C; Shimomura K; Nakanishi M; Yasuoka R; Aragane H; Hagiwara A; Abe T; Inazawa J; Yamagishi H
Hepatogastroenterology; 2003; 50(54):1857-63. PubMed ID: 14696419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
